负载剂量阿托瓦斯塔丁和罗斯瓦斯塔丁在脑梗塞中的疗效和安全性比较
Yanchao Li1, Di Zhang1, Shuang Liu2
1Department of Clinical Pharmacy, The Third Affiliated Hospital of Qiqihar Medical University No. 3, Taishun Street, Tiefeng District, Qiqihar 161000, Heilongjiang, China.
American journal of translational research
|October 14, 2024
概括
填充剂量的他类药物可以提高脑梗塞 (CI) 的临床疗效. 罗斯瓦斯塔丁提供比阿托瓦斯塔丁更好的脂质控制,在CI患者中具有类似的安全性.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑梗塞 (CI) 是一个重大的健康挑战.
- 类药物对于控制CI至关重要,但最佳剂量策略需要研究.
研究的目的:
- 为了比较负载剂量阿托瓦斯塔丁与罗斯瓦斯塔丁在治疗脑梗塞 (CI) 中的疗效和安全性.
主要方法:
- 对151名CI患者进行了回顾性分析.
- 患者被分为四组:常规阿托瓦斯塔丁,加载剂量阿托瓦斯塔丁,常规罗斯瓦斯塔丁和加载剂量罗斯瓦斯塔丁.
- 结果包括NIHSS得分,临床疗效,脂质概况,肝功能,炎症,心肌指数和不良反应.
主要成果:
- 负载剂量他类药物显著降低了NIHSS得分,比常规剂量更多.
- 负载剂量阿托瓦斯塔丁和罗斯瓦斯塔丁都显示出高临床疗效,两者之间没有显著差异.
- 负载剂量罗斯瓦斯塔丁与负载剂量阿托瓦斯塔丁相比,显示出优越的血脂控制和较轻的炎症/心肌指数增加.
- 两组之间没有观察到肝功能或不良反应率的显著差异.
结论:
- 负载剂量阿托瓦斯塔丁和罗斯瓦斯塔丁在CI治疗中是有效和安全的.
- 罗斯瓦斯塔丁在降脂效应和潜在的炎症标志物方面具有优势.
- 这些发现支持在CI管理中使用加重剂量他类药物,特别是罗斯瓦斯塔丁.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
579
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
579
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3


